Primary Peritoneal Serous Papillary Adenocarcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Primary Peritoneal Serous Papillary Adenocarcinoma

subtype

Identifier: CI-CAN-00008306
Entity page: /cancer/primary-peritoneal-serous-papillary-adenocarcinoma ↗
Edges: 13

Neighbours: 8 drugs5 trials
Drawn: 13 of 13 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Primary Peritoneal Serous Papillary Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived8 of 8
→ investigated in trials for	Adavosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Primary Peritoneal Serous Papillary Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody

Primary Peritoneal Serous Papillary Adenocarcinoma studied in …STUDIED_INderived5 of 5
→ studied in	NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ALIAS · 5 trials mapped (2 active)	—	—	Primary Peritoneal Serous Papillary Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01116648Phase 1/Phase 2 · active not recruiting Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer · condition mapped ALIAS · 5 trials mapped (2 active)	—	—	Primary Peritoneal Serous Papillary Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02283658Phase 2 · completed Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ALIAS · 5 trials mapped (2 active)	—	—	Primary Peritoneal Serous Papillary Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · condition mapped ALIAS · 5 trials mapped (2 active)	—	—	Primary Peritoneal Serous Papillary Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00053235withdrawn Research Study in Patients With Advanced Ovarian Epithelial Cancer · condition mapped ALIAS · 5 trials mapped (2 active)	—	—	Primary Peritoneal Serous Papillary Adenocarcinoma	1	Observed	clinicaltrials	graph →